Anmeldung erfolgt in Kürze...
Details werden geladen...
NPPA slashes prices of 543 anti-cancer medicines from Nov 9 - Rediff.com India News
India's drug price regulator, NPPA, has revised downward the maximum retail price of 543 anti-cancer medicines, effective November 9. This follows an announcement enforcing trade margin rationalisation on 137 non-scheduled anti-cancer drugs, leading to significant price drops for several key brands.
Ähnliche Seiten
NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9 - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-caps-trade-margins-on-137-cancer-drugs-at-30-revised-prices-from-nov-9/articleshow/135015811.cms
Prices of 137 cancer drugs to fall by up to 70% from November 9 | India News - The Times of India
https://timesofindia.indiatimes.com/india/prices-of-137-cancer-drugs-to-fall-by-up-to-70-from-november-9/articleshow/135020339.cms
Cancer drug prices may fall up to 70% from November 9 — What to know | Today News
https://www.livemint.com/news/india/cancer-drug-prices-may-fall-up-to-70-from-november-9-what-to-know-11792271202157.html
Cancer drug price cuts: NPPA revises MRPs of 543 brands, Keytruda unchanged - India Today
https://www.indiatoday.in/health/story/cancer-drug-price-cuts-nppa-revises-543-brands-keytruda-unchanged-3026710-2026-10-28
'400 times the cost': SC slams govt over drug pricing, asks to cap all medicines - Rediff.com India News
https://www.rediff.com/news/report/400-times-the-cost-sc-slams-govt-over-drug-pricing-asks-to-cap-all-medicines/20261012.htm